NMDA-Antagonisten

European patent · EP0501378 · Deleted

Register entry

Publication number
EP0501378
Application number
EP92103066
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Feb 24, 1992
Published
Sep 2, 1992
Granted
Jan 11, 1995
Deleted
Feb 23, 2012
Reason
Maximum term reached
IPC classes
C07D 209/20 (2006.01)
C07C 229/42 (2006.01)
A61K 31/405 (2006.01)
A61K 31/19 (2006.01)
Priority
US A 662670 28.02.1991
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 27, 2012

    Maximum term reached

    Published in Swissreg on 27.02.2012

  2. Oct 15, 2007

    Address changed

    Representative
    E. Blum & Co. Patentanwälte, Am Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich

    Published in +pat+ No 19 in 2007

  3. Feb 28, 2006

    Address changed

    Owner
    Merrell Dow Pharmaceuticals Inc., 2110 E. Galbraith Road, Cincinnati/OH, USA → MERRELL PHARMACEUTICALS INC., 2110 East Galbraith Road,, P.O. Box 156300, Cincinnati,, Ohio 45215-6300, USA

    Published in +pat+ No 4 in 2006

  4. Feb 28, 2006

    Transferred

    Owner
    MERRELL PHARMACEUTICALS INC., 2110 East Galbraith Road,, P.O. Box 156300, Cincinnati,, Ohio 45215-6300, USA → Aventis, Inc., 300 Somerset Corporate Boulevard, Bridgewater, NJ 08807, USA

    Published in +pat+ No 4 in 2006

  5. Feb 28, 1995

    Granted

    Published in PIDTJ No 4 in 1995

Parties

Inventor

Palfreyman, Michael G.

Cincinnati, Ohio 45249, US

McDonald, Ian A.

Loveland, Ohio 45140, US

Salituro, Francesco G.

Fairfield, Ohio 45014, US

Schwarcz, Robert

Baltimore, Maryland 21209, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.